Orbimed-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "AXSM",
  "EWTX",
  "TRVI",
  "INSM",
  "FBRX",
  "KRYS",
  "ORIC",
  "TIL",
  "ARGX",
  "CBLL",
  "EXAS",
  "APLS",
  "ALNY",
  "ABCL",
  "FOLD",
  "ITGR",
  "BSX",
  "SWTX",
  null,
  "BCAX",
  "SLRN",
  "AVBP",
  "TNGX",
  "GPCR",
  "IMTX",
  "THRD",
  "TERN",
  "TYRA",
  "ACET",
  "ADCT",
  "KROS",
  "GILD",
  "ANRO",
  "AVTX",
  "AMLX",
  "JANX",
  "BIOA",
  "PHGE",
  "DHAI",
  "SRRK",
  "FATE",
  "ISRG",
  "TARS",
  "IVVD",
  "NBIX",
  "KRRO",
  "NXTC",
  "NKTX",
  "PMVP",
  "PRLD",
  "QTTB",
  "RPTX",
  "SIBN",
  "TSBX",
  "WHWK",
  "IONS",
  null,
  null,
  "UNH",
  "PFE",
  "SPRY",
  "AMGN",
  "SYK",
  "TMO",
  null,
  "UPB",
  "RAPT",
  "TRAW",
  "RNA",
  "AGIO",
  "MBX",
  "NPCE",
  "RYTM",
  "DYN",
  "SCPH",
  "PASG",
  null,
  "VRTX",
  "EW",
  "THC",
  "NTRA",
  null,
  null,
  "CRVS",
  "ELVN",
  "IKNA",
  null,
  "KZR",
  "VSTM",
  "VIR",
  "XERS",
  "XFOR",
  "XENE",
  "XTNT",
  "VERA",
  null,
  "CCCC",
  "CRDF",
  "CGON",
  "CMPX",
  "CRBP",
  "CRNX",
  "CGEM",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 107
Total Value: 4035711615
Accession Number: 0001172661-25-002355
Form Type: 13F-HR
CIK: orbimed-advisors
Manager Name: Orbimed-Advisors

Data Enrichment

92% identified

98 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

107 positions • $4.0B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 6

Sort by:

Janux Therapeutics, Inc.

JANX|47103J105

Shares:758.6K

Value:$20.5M

% of Portfolio:0.5% ($20.5M/$4.0B)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:380.0K

Value:$20.1M

% of Portfolio:0.5% ($20.1M/$4.0B)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:5.8M

Value:$20.1M

% of Portfolio:0.5% ($20.1M/$4.0B)

AMICUS THERAPEUTICS, INC.

FOLD|03152W109

Shares:2.3M

Value:$18.6M

% of Portfolio:0.5% ($18.6M/$4.0B)

Verastem, Inc.

VSTM|92337C203

Shares:2.9M

Value:$17.3M

% of Portfolio:0.4% ($17.3M/$4.0B)

Tyra Biosciences, Inc.

TYRA|90240B106

Shares:1.8M

Value:$16.3M

% of Portfolio:0.4% ($16.3M/$4.0B)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:13.1M

Value:$16.0M

% of Portfolio:0.4% ($16.0M/$4.0B)

scPharmaceuticals Inc.

SCPH|810648105

Shares:6.1M

Value:$15.9M

% of Portfolio:0.4% ($15.9M/$4.0B)

Vir Biotechnology, Inc.

VIR|92764N102

Shares:2.2M

Value:$14.6M

% of Portfolio:0.4% ($14.6M/$4.0B)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:1.9M

Value:$14.6M

% of Portfolio:0.4% ($14.6M/$4.0B)

Immatics N.V.

IMTX|N44445109

Shares:3.1M

Value:$13.9M

% of Portfolio:0.3% ($13.9M/$4.0B)

AMGEN INC

AMGN|031162100

Shares:44.2K

Value:$13.8M

% of Portfolio:0.3% ($13.8M/$4.0B)

PFIZER INC

PFE|717081103

Shares:500.0K

Value:$12.7M

% of Portfolio:0.3% ($12.7M/$4.0B)

Vera Therapeutics, Inc.

VERA|92337R101

Shares:481.1K

Value:$11.6M

% of Portfolio:0.3% ($11.6M/$4.0B)

C4 Therapeutics, Inc.

CCCC|12529R107

Shares:6.8M

Value:$10.9M

% of Portfolio:0.3% ($10.9M/$4.0B)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:1.0M

Value:$10.6M

% of Portfolio:0.3% ($10.6M/$4.0B)

Keros Therapeutics, Inc.

KROS|492327101

Shares:1.0M

Value:$10.4M

% of Portfolio:0.3% ($10.4M/$4.0B)

ACELYRIN, Inc.

SLRN|00445A100

Shares:4.0M

Value:$9.9M

% of Portfolio:0.2% ($9.9M/$4.0B)

AGIOS PHARMACEUTICALS, INC.

AGIO|00847X104

Shares:325.5K

Value:$9.5M

% of Portfolio:0.2% ($9.5M/$4.0B)

AbCellera Biologics Inc.

ABCL|00288U106

Shares:4.2M

Value:$9.3M

% of Portfolio:0.2% ($9.3M/$4.0B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Janux Therapeutics, Inc.(JANXcusip47103J105)	758.6K	QoQ 0.00% (-0) YoY -82.25% (-3.5M)	All Managers (Combined)	$20.5M	0.5% ($20.5M/$4.0B)	QoQ -49.57% (-$20.1M) YoY -87.27% (-$140.5M)
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	380.0K	QoQ -5.00% (-20.0K) YoY -46.08% (-324.8K)	All Managers (Combined)	$20.1M	0.5% ($20.1M/$4.0B)	QoQ -10.10% (-$2.3M) YoY -34.09% (-$10.4M)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	5.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$20.1M	0.5% ($20.1M/$4.0B)	QoQ -66.27% (-$39.4M) YoY -63.24% (-$34.5M)
AMICUS THERAPEUTICS, INC.(FOLDcusip03152W109)	2.3M	QoQ 0.00% (-0) YoY +300.73% (+1.7M)	All Managers (Combined)	$18.6M	0.5% ($18.6M/$4.0B)	QoQ -13.37% (-$2.9M) YoY +177.58% (+$11.9M)
Verastem, Inc.(VSTMcusip92337C203)	2.9M	QoQ 0.00% (+0) YoY +87.19% (-1.3M)	All Managers (Combined)	$17.3M	0.4% ($17.3M/$4.0B)	QoQ +16.63% (+$2.5M) YoY -4.33% (-$783.0K)
Tyra Biosciences, Inc.(TYRAcusip90240B106)	1.8M	QoQ +19.23% (-282.7K) YoY +128.04% (+984.2K)	All Managers (Combined)	$16.3M	0.4% ($16.3M/$4.0B)	QoQ -20.22% (-$4.1M) YoY +29.31% (+$3.7M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	13.1M	QoQ 0.00% (-0) YoY NEW(+13.1M)	All Managers (Combined)	$16.0M	0.4% ($16.0M/$4.0B)	QoQ -22.78% (-$4.7M) YoY NEW(+$16.0M)
scPharmaceuticals Inc.(SCPHcusip810648105)	6.1M	QoQ 0.00% (-0) YoY +8.99% (-500.0K)	All Managers (Combined)	$15.9M	0.4% ($15.9M/$4.0B)	QoQ -25.70% (-$5.5M) YoY -42.89% (-$12.0M)
Vir Biotechnology, Inc.(VIRcusip92764N102)	2.2M	QoQ -30.14% (-970.4K) YoY +251.28% (+1.6M)	All Managers (Combined)	$14.6M	0.4% ($14.6M/$4.0B)	QoQ -38.33% (-$9.1M) YoY +124.71% (+$8.1M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	1.9M	QoQ -0.96% (-18.7K) YoY +271.68% (+1.4M)	All Managers (Combined)	$14.6M	0.4% ($14.6M/$4.0B)	QoQ -38.44% (-$9.1M) YoY +65.11% (+$5.7M)
Immatics N.V.(IMTXcusipN44445109)	3.1M	QoQ 0.00% (-0) YoY +74.46% (-1.3M)	All Managers (Combined)	$13.9M	0.3% ($13.9M/$4.0B)	QoQ -36.56% (-$8.0M) YoY -25.13% (-$4.7M)
AMGEN INC(AMGNcusip031162100)	44.2K	QoQ NEW(+44.2K) YoY -30.28% (-19.2K)	All Managers (Combined)	$13.8M	0.3% ($13.8M/$4.0B)	QoQ NEW(+$13.8M) YoY -23.60% (-$4.3M)
PFIZER INC(PFEcusip717081103)	500.0K	QoQ +100.00% (+250.0K) YoY NEW(+500.0K)	All Managers (Combined)	$12.7M	0.3% ($12.7M/$4.0B)	QoQ +91.02% (+$6.0M) YoY NEW(+$12.7M)
Vera Therapeutics, Inc.(VERAcusip92337R101)	481.1K	QoQ -35.21% (-261.5K) YoY -28.82% (-194.8K)	All Managers (Combined)	$11.6M	0.3% ($11.6M/$4.0B)	QoQ -63.20% (-$19.8M) YoY -60.35% (-$17.6M)
C4 Therapeutics, Inc.(CCCCcusip12529R107)	6.8M	QoQ +4453.53% (+6.7M) YoY NEW(+6.8M)	All Managers (Combined)	$10.9M	0.3% ($10.9M/$4.0B)	QoQ +1923.79% (+$10.4M) YoY NEW(+$10.9M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	1.0M	QoQ -17.31% (-212.5K) YoY +43.22% (-306.2K)	All Managers (Combined)	$10.6M	0.3% ($10.6M/$4.0B)	QoQ -63.29% (-$18.3M) YoY -47.22% (-$9.5M)
Keros Therapeutics, Inc.(KROScusip492327101)	1.0M	QoQ 0.00% (-0) YoY -19.70% (-250.0K)	All Managers (Combined)	$10.4M	0.3% ($10.4M/$4.0B)	QoQ -35.62% (-$5.7M) YoY -87.64% (-$73.6M)
ACELYRIN, Inc.(SLRNcusip00445A100)	4.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.9M	0.2% ($9.9M/$4.0B)	QoQ -21.33% (-$2.7M) YoY -63.40% (-$17.1M)
AGIOS PHARMACEUTICALS, INC.(AGIOcusip00847X104)	325.5K	QoQ +1119.10% (+298.8K) YoY NEW(+325.5K)	All Managers (Combined)	$9.5M	0.2% ($9.5M/$4.0B)	QoQ +987.02% (+$8.7M) YoY NEW(+$9.5M)
AbCellera Biologics Inc.(ABCLcusip00288U106)	4.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.3M	0.2% ($9.3M/$4.0B)	QoQ -23.89% (-$2.9M) YoY -50.77% (-$9.6M)